DK112589B - Fremgangsmåde til fremstilling af 2,3,5,6-tetrahydroimidazo[2,1-b]thiazoler eller syreadditionssalte deraf. - Google Patents

Fremgangsmåde til fremstilling af 2,3,5,6-tetrahydroimidazo[2,1-b]thiazoler eller syreadditionssalte deraf.

Info

Publication number
DK112589B
DK112589B DK638166AA DK638166A DK112589B DK 112589 B DK112589 B DK 112589B DK 638166A A DK638166A A DK 638166AA DK 638166 A DK638166 A DK 638166A DK 112589 B DK112589 B DK 112589B
Authority
DK
Denmark
Prior art keywords
tetrahydroimidazo
thiazoles
preparation
acid addition
addition salts
Prior art date
Application number
DK638166AA
Other languages
English (en)
Inventor
A Raeymaekers
D Thienpont
P Demoen
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of DK112589B publication Critical patent/DK112589B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/40Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK638166AA 1964-05-11 1966-12-09 Fremgangsmåde til fremstilling af 2,3,5,6-tetrahydroimidazo[2,1-b]thiazoler eller syreadditionssalte deraf. DK112589B (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36663864A 1964-05-11 1964-05-11
US38723164A 1964-08-03 1964-08-03
US40125164A 1964-10-02 1964-10-02
US446408A US3274209A (en) 1964-05-11 1965-04-07 Certain 6-substituted-imidazo[2, 1-b] thiazole compounds
US553595A US3364112A (en) 1964-05-11 1966-03-21 Compositions and methods employing certain 6-substituted-imidazo(2, 1-b) thiazoles as anthelmintics

Publications (1)

Publication Number Publication Date
DK112589B true DK112589B (da) 1968-12-30

Family

ID=27541299

Family Applications (3)

Application Number Title Priority Date Filing Date
DK237665AA DK122888B (da) 1964-05-11 1965-05-11 Fremgangsmåde til fremstilling af imidazo[2,1-b]thiazoler eller syreadditionssalte deraf.
DK638266AA DK113148B (da) 1964-05-11 1966-12-09 Fremgangsmåde til fremstilling af 5,6-dihydro-imidazo[2,1-b]thiazoler eller syreadditionssalte deraf.
DK638166AA DK112589B (da) 1964-05-11 1966-12-09 Fremgangsmåde til fremstilling af 2,3,5,6-tetrahydroimidazo[2,1-b]thiazoler eller syreadditionssalte deraf.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK237665AA DK122888B (da) 1964-05-11 1965-05-11 Fremgangsmåde til fremstilling af imidazo[2,1-b]thiazoler eller syreadditionssalte deraf.
DK638266AA DK113148B (da) 1964-05-11 1966-12-09 Fremgangsmåde til fremstilling af 5,6-dihydro-imidazo[2,1-b]thiazoler eller syreadditionssalte deraf.

Country Status (17)

Country Link
US (2) US3274209A (da)
BE (1) BE663591A (da)
BR (1) BR6569567D0 (da)
CH (2) CH463513A (da)
CS (3) CS158182B2 (da)
DE (1) DE1545995C3 (da)
DK (3) DK122888B (da)
ES (1) ES312813A1 (da)
FI (1) FI47193C (da)
FR (1) FR4705M (da)
GB (1) GB1043489A (da)
IL (1) IL23501A (da)
IT (1) IT1053975B (da)
MY (1) MY6900207A (da)
NL (2) NL6505806A (da)
NO (1) NO117369B (da)
SE (2) SE353095B (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4059588A (en) * 1965-07-19 1977-11-22 Ici Australia Limited Process for preparing 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole
NL129632C (da) * 1965-12-10
US3673206A (en) * 1969-04-02 1972-06-27 American Cyanamid Co RACEMIZATION OF d({30 ) 6-PHENYL-2,3,5,6-TETRAHYDROIMIDAZO {8 2,1-b{9 Thiazole
ZA704419B (en) * 1969-07-21 1971-04-28 Ici Australia Ltd Injectable aqueous solutions of tetramisole
GB1287674A (en) * 1969-07-21 1972-09-06 Ici Australia Ltd Injectable compositions
BR6915163D0 (pt) * 1969-12-15 1973-05-31 Cyanamid Co American Processo quimico
US3673205A (en) * 1970-03-25 1972-06-27 American Cyanamid Co 6-(m-AMINO AND SUBSTITUTED-AMINO PHENYL)-2,3,5,6-TETRAHYDRO{8 2,1-b{9 THIAZOLES AND METHOD OF USE
US3878222A (en) * 1972-03-13 1975-04-15 American Cyanamid Co Methods of preparing substituted imidazothiazolium compounds
US3852458A (en) * 1972-08-11 1974-12-03 Janssen Pharmaceutica Nv Antidepressive activity of tetramisole
DE2340633C2 (de) * 1972-08-17 1985-09-05 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische Verwendung von 2,3,5,6-Tetrahydro-6-phenylimidazo[2,1-b]thiazol
DE2340632C2 (de) * 1972-08-17 1985-09-05 Janssen Pharmaceutica, N.V., Beerse Verwendung von 2,3,5,6-Tetrahydro-6-phenylimidazo[2,1-b]thiazol oder von dessen Salzen bei der unterstützenden Behandlung zur Rückbildung und Linderung von Neoplasmen
IE38848B1 (en) * 1973-02-23 1978-06-07 Fisons Ltd Anthelmintic method and composition
US3860718A (en) * 1973-09-20 1975-01-14 Pfizer IMIDAZO (2,1-b) THIAZOLE AND THIAZOLO (3,2-a) BENZIMIDAZOLE QUATERNARY SALTS HYPOGLYCEMIC AGENTS
US4042583A (en) * 1973-09-20 1977-08-16 Pfizer Inc. Imidazo[2,1-b]thiazole and thiazolo[3,2-a]-benzimidazole quaternary salts as hypoglycemic agents and growth promotants
GB1541321A (en) * 1976-03-10 1979-02-28 Metabio 2,3-dihydroimidazo(2,1-b)thiazole derivatives and process for their preparation
GB1516938A (en) * 1976-05-01 1978-07-05 Pfizer Ltd Halopyridylamides of m-aminotetramisole and their use as anthelmintics
US4263311A (en) * 1976-09-27 1981-04-21 Smithkline Corporation 5,6-Phenyl-2,3-dihydroimidazo [2,1-b] thiazoles
GB1533347A (en) * 1976-10-22 1978-11-22 Pfizer Ltd Anthelmintic compounds
US4150141A (en) * 1977-06-28 1979-04-17 Johnson & Johnson Treatment for scabies
LU77703A1 (de) * 1977-07-07 1979-03-26 Ciba Geigy Ag Verfahren zur herstellung von bicyclischen thia-diaza-verbindungen
US4104400A (en) * 1977-07-08 1978-08-01 E. R. Squibb & Sons, Inc. Imidazo(2,1-b)thiazole derivatives, compositions containing same, and method of treating helminthiasis
US4153706A (en) * 1978-02-13 1979-05-08 Smithkline Corporation 6-Hydroxy-5,6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazoles
US4153678A (en) * 1978-07-17 1979-05-08 American Cyanamid Company Levamisole effervescent tablets
CA1131226A (en) * 1978-09-28 1982-09-07 Tomohiko Munakata Heterocyclic compounds
PL221188A1 (da) * 1979-01-05 1980-12-01 Ciba Geigy Ag
DE3162522D1 (en) * 1980-09-04 1984-04-12 Janssen Pharmaceutica Nv A new method of preparing 3-(2-hydroxy-2-arylethyl)-2-iminothiazolidines
CA1194791A (en) * 1981-05-08 1985-10-08 John M. Ballany Parasiticidal pour-on compositions
US4376769A (en) * 1981-06-19 1983-03-15 Schering Corporation Substituted imidazo thiazoles thiazines, thiazepines and thiazocines
AU1611383A (en) * 1982-07-02 1984-01-05 Robert Young & Company Limited Pesticidal formulation with cypermethrin
ZW24186A1 (en) * 1985-12-12 1987-07-08 Smithkline Beckman Corp Inhibition of the 5-lipoxygenase pathway
US5527915A (en) * 1989-11-24 1996-06-18 Janssen Pharmaceutica N.V. Immunostimulating 6-aryl-5,6-dihydroimidazo[2,1-beta]thiazole derivatives
US5212192A (en) * 1989-11-24 1993-05-18 Janssen Pharmaceutica N.V. Immunostimulating 6-aryl-5,6-dihydroimidazo[2,1-b]thiazole derivatives
US5516647A (en) * 1993-11-05 1996-05-14 Abbott Laboratories Compounds useful as alkaline phosphatase inhibitors and therapeutic agents
JP2001302635A (ja) * 2000-04-21 2001-10-31 Suntory Ltd 新規複素環化合物
US8067382B2 (en) * 2002-01-08 2011-11-29 Merial Limited Anthelmintic composition
GB201909771D0 (en) * 2019-07-08 2019-08-21 Governing Council Of The Univ Of Toronto Imidazothiazole compounds and methods for treating plant nematode infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2775538A (en) * 1951-06-04 1956-12-25 Boskamp Arthur Stabilized hexylresorcinol therapeutic agent containing castor oil
US2799617A (en) * 1953-10-21 1957-07-16 British Drug Houses Ltd Piperazine adipate compositions and treatment of helminth infections therewith
US2969369A (en) * 1959-10-23 1961-01-24 Searle & Co Derivatives of 3-phenyl-5, 6-dihydroimidazo-[2. 1-b] thiazoles
US3147273A (en) * 1963-05-02 1964-09-01 Upjohn Co Certain 2h-isothiazolo [4, 5-b] indol-3 (4h)-one 1-oxide compounds and their preparation

Also Published As

Publication number Publication date
US3364112A (en) 1968-01-16
IL23501A (en) 1968-11-27
FI47193B (da) 1973-07-02
GB1043489A (en) 1966-09-21
FI47193C (fi) 1973-10-10
CH463513A (fr) 1968-10-15
CH440285A (fr) 1967-07-31
BE663591A (da) 1965-11-08
IT1053975B (it) 1981-10-10
CS158180B2 (da) 1974-10-15
DE1545995C3 (de) 1973-11-22
DE1545995B2 (de) 1973-04-26
US3274209A (en) 1966-09-20
DK122888B (da) 1972-04-24
SE321237B (da) 1970-03-02
CS158181B2 (da) 1974-10-15
ES312813A1 (es) 1966-02-16
DK113148B (da) 1969-02-24
DE1545995A1 (de) 1969-11-13
NL131034C (da)
CS158182B2 (da) 1974-10-15
MY6900207A (en) 1969-12-31
NL6505806A (da) 1965-11-12
FR4705M (da) 1966-12-26
NO117369B (da) 1969-08-04
SE353095B (da) 1973-01-22
BR6569567D0 (pt) 1973-08-02

Similar Documents

Publication Publication Date Title
DK112589B (da) Fremgangsmåde til fremstilling af 2,3,5,6-tetrahydroimidazo[2,1-b]thiazoler eller syreadditionssalte deraf.
DK130070B (da) Analogifremgangsmåde til fremstilling af 3,4-dihydroxyphenylalkanolaminer eller syreadditionssalte deraf.
DK105984C (da) Fremgangsmåde til fremstilling af 1,5-disubstituerede 1,4-benzodiazepinderivater eller syreadditionssalte deraf.
DK124404B (da) Fremgangsmåde til fremstilling af 2-arylamino-1,3-diazacycloalkener-(2) eller syreadditionssalte deraf.
DK107288C (da) Fremgangsmåde til fremstilling af arylalkylaminoguanidiner eller syreadditionssalte deraf.
DK114618B (da) Fremgangsmåde til fremstilling af α-dithiosemicarbazoner eller syreadditionssalte deraf.
DK131940B (da) Analogifremgangsmåde til fremstilling af 2,6-diphenyl-3-methyl-2,3-dihydro-imidazo/2,1-b/thiazol eller syreadditionssalte deraf.
DK115851B (da) Fremgangsmåde til fremstilling af 1,2-dihydro-4-aryl-quinazoliner eller syreadditionssalte deraf.
DK122327B (da) Analogifremgangsmåde til fremstilling af N-alkyllincomycin D-forbindelser eller syreadditionssalte deraf.
DK121367B (da) Analogifremgangsmåde til fremstilling af 3,3-difenylallylaminderivater eller syreadditionssalte deraf.
DK130246B (da) Analogifremgangsmåde til fremstilling af 11-piperazinyldibenz[b,f][1,4]oxazepiner eller -thiazepiner eller syreadditionssalte deraf.
DK107874C (da) Fremgangsmåde til fremstilling af imidazo-[2,1-b]-thiazol- eller benzothiazolforbindelser eller syreadditionssalte heraf.
DK118668B (da) Fremgangsmåde til fremstilling af tetrahydro-1,3,5-thiadiazin-2-thioner eller syreadditionssalte deraf.
DK118657B (da) Analogifremgangsmåde til fremstilling af 3',4',5'-trimethoxy-3-aminoacrylophenoner eller syreadditionssalte deraf.
DK115703B (da) Fremgangsmåde til fremstilling af N-alkylpolyhydrobenzazepinopyridoindoler eller syreadditionssalte deraf.
DK119826B (da) Fremgangsmåde til fremstilling af α-6-deoxytetracyclin, α-6-deoxy-5-oxytetracyclin eller syreadditionssalte deraf.
DK112524B (da) Fremgangsmåde til fremstilling af N-aralkylpiperidin-derivater eller syreadditionssalte deraf.
DK119705B (da) Fremgangsmåde til fremstilling af 4,5-disubstituerede 2-alkyl-3-hydroxy-pyridiner eller syreadditionssalte deraf.
DK125552B (da) Fremgangsmåde til fremstilling af 1,2,3,4-tetrahydroisoquinolin-2-carboxamidiner eller syreadditionssalte deraf.
DK121375B (da) Analogifremgangsmåde til fremstilling af N-aminoalkylbenzazacycloalkanderivater eller syreadditionssalte heraf.
DK112385B (da) Fremgangsmåde til fremstilling af N-guanyl-3-azabicyclo[3,2,0]heptan-3-carbonxamidin eller syreadditionssalte heraf.
DK107227C (da) Fremgangsmåde til fremstilling af 3,8-diazabicyklooktanderivater af fentiaziner, eller syreadditionssalte deraf.
DK115332B (da) Fremgangsmåde til fremstilling af 3-methyl-9α-phenyl-9β-alkoxy-3-azabicyclo[3,3,1]nonaner eller syreadditionssalte deraf.
DK114472B (da) Fremgangsmåde til fremstilling af lincomycin D, N-demethylcelesticetin eller N-demethyldesalicetin eller syreadditionssalte deraf.
DK106144C (da) Fremgangsmåde til fremstilling af aryl-N-(1,2,5,6-tetrahydro-1,3-dialkyl-4-pyridyl)-alkanoylamider eller syreadditionssalte deraf.